NCT03975088View on ClinicalTrials.gov

Sub-macular Injection of Ranibizumab as a New Surgical Treatment for Refractory Diabetic Macular Edema

NACompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

January 1, 2017

Primary Completion Date

December 31, 2017

Study Completion Date

December 31, 2018

Conditions
Diabetic Macular Edema
Interventions
PROCEDURE

Sub-macular injection of Ranibizumab

In this study, authors describe a new surgical technique for the treatment of refractory non tractional DME. The technique consists of vitrectomy with ILM peeling with subretinal injection of Ranibizumab.

All Listed Sponsors
lead

University of Alexandria

OTHER

NCT03975088 - Sub-macular Injection of Ranibizumab as a New Surgical Treatment for Refractory Diabetic Macular Edema | Biotech Hunter | Biotech Hunter